Yuki Miyamoto, MD, MPH; Hiroyuki Ohbe, MD, MPH; Ryosuke Kumazawa, DPH; et al.
free access
JAMA Dermatol. 2023;159(5):481-487. doi:10.1001/jamadermatol.2023.0035
This retrospective cohort study evaluated the outcomes of administering plasmapheresis or intravenous immunoglobulin therapy first after ineffective systemic corticosteroid treatment among inpatients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan.
Gabriella Santa Lucia, MD, MSCR; Alan Snyder, MD, MSCR; Almeera Lateef, BS; et al.
free access
JAMA Dermatol. 2023;159(5):488-495. doi:10.1001/jamadermatol.2023.0205
This randomized clinical trial of 31 adult patients in the US evaluates and compares the safety and efficacy of topical lovastatin plus cholesterol cream vs topical lovastatin cream for the treatment of disseminated superficial actinic porokeratosis.
Kailas Vodrahalli, BS; Justin Ko, MD, MBA; Albert S. Chiou, MD, MBA; et al.
free access
has audio
JAMA Dermatol. 2023;159(5):496-503. doi:10.1001/jamadermatol.2023.0091
This quality improvement study assesses whether patient use of an artificial intelligence (AI) algorithm was associated with improved photo quality of skin lesion images taken by patients for telemedical use.
-
Podcast:
AI Support Tool for Telemedicine
Aaron Gabriel W. Sandoval, MPhil, MSc; Lauren T. Vaughn, BSc; Jennifer T. Huang, MD; et al.
free access
JAMA Dermatol. 2023;159(5):504-509. doi:10.1001/jamadermatol.2023.0269
This systematic review examines the demographic characteristics, clinical presentations, treatments, and outcomes of patients receiving tumor necrosis factor鈥撐� inhibitors (TNFis) to treat acne and patients who develop acne following treatment of other conditions with TNFis.
Leandra A. Barnes, MD; Neha Shukla, MD; Maia Paul, MPH; et al.
free access
JAMA Dermatol. 2023;159(5):510-517. doi:10.1001/jamadermatol.2023.0486
This qualitative study characterizes the health care experiences of people living with hidradenitis suppurativa, including perceived barriers and facilitators to health care access, and elucidates potential associations among these barriers and facilitators, health care access, and disease activity.
Marita Jenssen, MD; Anne-Sofie Furberg, MD, PhD; Rolf Jorde, MD, PhD; et al.
free access
JAMA Dermatol. 2023;159(5):518-525. doi:10.1001/jamadermatol.2023.0357
This randomized clinical trial examines the effect of vitamin D supplementation on psoriasis severity throughout the winter.
Amy S. Paller, MD, MS; Barry Ladizinski, MD, MPH, MBA; Pedro Mendes-Bastos, MD; et al.
open access
JAMA Dermatol. 2023;159(5):526-535. doi:10.1001/jamadermatol.2023.0391
This analysis of 3 randomized clinical trials assesses the efficacy and safety of upadacitinib to treat moderate-to-severe atopic dermatitis in adolescents.